NU6300 is a non-covalent ATP-competitive CDK2 inhibitor (IC50 = 0.16 mM).
NU6300 is a non-covalent ATP-competitive CDK2 inhibitor (IC50 = 0.16 mM).in vitro: NU6300 is a covalent CDK2 inhibitor that illustrates the potential of using vinyl sulfones to mediate irreversible inhibition. NU6300 blocks the inhibitor binding site. The effect was time dependent and relatively slow, with less than 50% reduction of the apparent binding capacity in 20 hr.
For research and scientific purpose only, not for human use!
没有评论:
发表评论